Dalogdog, Rheanne Jane S.

HRN: 22-35-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
CEFUROXIME 750MG (VIAL)
07/09/2023
07/15/2023
IV
250mg
Q8
PCAP C
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: